Insider · CIK 0001196863
VITULLO NICOLE
Reports to the SEC for 33 companies · PRINCETON, NJ
Transactions
50
Companies
33
Filings
11
CIK
0001196863
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-05-29 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2024-05-23 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2023-06-15 | ESPREsperion Therapeutics, Inc.A Award | — |
| 2023-06-15 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-05-26 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-02-04 | MARINUS PHARMACEUTICALS, INC.A Award | — |
| 2022-02-04 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award | — |
| 2021-05-27 | ESPREsperion Therapeutics, Inc.A Award | — |
| 2021-03-16 | MARINUS PHARMACEUTICALS, INC.J Other | — |
| 2021-03-16 | MARINUS PHARMACEUTICALS, INC.J Other | — |
| 2021-03-16 | MARINUS PHARMACEUTICALS, INC.J Other | — |
| 2021-03-15 | MARINUS PHARMACEUTICALS, INC.S Sale | −$67.4K |
| 2021-03-12 | MARINUS PHARMACEUTICALS, INC.J Other | — |
| 2021-03-12 | MARINUS PHARMACEUTICALS, INC.J Other | — |
| 2021-01-15 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award | — |
| 2020-05-28 | ESPREsperion Therapeutics, Inc.A Award | — |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCD Disposition to Issuer | −$230K |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCD Disposition to Issuer | −$21.4M |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCD Disposition to Issuer | −$159K |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2020-01-08 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award | — |
| 2020-01-08 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award | — |
| 2019-05-29 | ESPREsperion Therapeutics, Inc.A Award | — |
| 2019-03-21 | ESPREsperion Therapeutics, Inc.J Other | — |
| 2019-03-21 | ESPREsperion Therapeutics, Inc.J Other | — |
| 2019-03-19 | ESPREsperion Therapeutics, Inc.J Other | — |
| 2019-03-19 | ESPREsperion Therapeutics, Inc.J Other | — |
| 2019-03-19 | ESPREsperion Therapeutics, Inc.S Sale | −$609K |
| 2019-03-19 | ESPREsperion Therapeutics, Inc.S Sale | −$76.9K |
| 2019-02-26 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award | — |
| 2019-01-23 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
| 2018-06-22 | ESPREsperion Therapeutics, Inc.J Other | — |
| 2018-06-22 | ESPREsperion Therapeutics, Inc.J Other | — |
| 2018-05-31 | ACHILLION PHARMACEUTICALS INCJ Other | — |
| 2018-05-31 | ACHILLION PHARMACEUTICALS INCJ Other | — |
| 2018-05-23 | ESPREsperion Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2018-02-09 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
| 2018-01-26 | ESPREsperion Therapeutics, Inc.J Other | — |
| 2018-01-26 | ESPREsperion Therapeutics, Inc.J Other | — |
| 2018-01-25 | ESPREsperion Therapeutics, Inc.S Sale | −$838K |
| 2018-01-24 | ESPREsperion Therapeutics, Inc.J Other | — |
| 2018-01-24 | ESPREsperion Therapeutics, Inc.J Other | — |
Recent filings
- 4VITULLO NICOLE0001628280-25-028822SEC(opens sec.gov)
- 4VITULLO NICOLE0001628280-24-025206SEC(opens sec.gov)
- 4VITULLO NICOLE0001628280-23-022455SEC(opens sec.gov)
- 4VITULLO NICOLE0001628280-22-015589SEC(opens sec.gov)
- 4VITULLO NICOLE0001104659-22-012796SEC(opens sec.gov)
- 4VITULLO NICOLE0001628280-21-011357SEC(opens sec.gov)
- 4VITULLO NICOLE0000904454-21-000348SEC(opens sec.gov)
- 4VITULLO NICOLE0000904454-21-000034SEC(opens sec.gov)
- 4/AVITULLO NICOLE0000904454-20-000703SEC(opens sec.gov)
- 4VITULLO NICOLE0001179110-20-006715SEC(opens sec.gov)
- 4VITULLO NICOLE0000904454-20-000088SEC(opens sec.gov)
Companies
- Achaogen, Inc.10% Owner
- ACHILLION PHARMACEUTICALS INCDirector
- Adynxx, Inc.10% Owner
- ALIMERA SCIENCES INC10% Owner
- Atara Biotherapeutics, Inc.10% OwnerATRA
- aTYR PHARMA INC10% OwnerATYR
- Bionano Genomics, Inc.10% OwnerBNGO
- CADENCE PHARMACEUTICALS INC10% Owner
- Celator Pharmaceuticals IncDirector
- Clovis Oncology, Inc.10% Owner
- CoLucid Pharmaceuticals, Inc.10% Owner
- CORVAS INTERNATIONAL INCInsider
- Dicerna Pharmaceuticals Inc10% Owner
- Durata Therapeutics, Inc.Director, 10% Owner
- Esperion Therapeutics, Inc.DirectorESPR
- Evofem Biosciences, Inc.10% OwnerEVFM
- Evoke Pharma Inc10% OwnerEVOK
- GLAUKOS Corp10% OwnerGKOS
- MARINUS PHARMACEUTICALS, INC.Director
- Northstar Neuroscience, Inc.10% Owner
- Ocera Therapeutics, Inc.10% Owner
- ONYX PHARMACEUTICALS INCDirector
- Orexigen Therapeutics, Inc.10% Owner
- OTONOMY, INC.10% Owner
- Pernix Sleep, Inc.10% Owner
- Syndax Pharmaceuticals Inc10% OwnerSNDX
- TANDEM DIABETES CARE INC10% OwnerTNDM
- Tobira Therapeutics, Inc.10% Owner
- Vanda Pharmaceuticals Inc.10% OwnerVNDA
- VERACYTE, INC.10% OwnerVCYT
- Volcano Corp10% Owner
- Vyome Holdings, Inc10% OwnerHIND
- ZOGENIX, INC.10% Owner
Address
C/O DOMAIN ASSOCIATES, LLC ONE PALMER SQUARE
PRINCETON, NJ, 08542